Client News

Philikos Announces Initiation of Clinical Phase 1/2 Study with T-Guard® in Patients with Systemic Sclerosis

Journal of Critical Care Publishes Positive Results from Prespecified, Biomarker-guided Subgroup Analysis of AdrenoMed’s Phase II AdrenOSS-2 Trial in Septic Shock

Rentschler Biopharma Achieves ISO 50001 Certification for Energy Management

Formycon and Fresenius Kabi Announce FDA Approval of Interchangeability for FYB202/Otulfi®(ustekinumab-aauz)

PL BioScience and DewCell sign LOI to Jointly Develop Artificial Human Platelets for Scalable, Animal-Free Cell Culture Media

Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study

Viromed Medical AG: Revolutionary Cold Plasma Therapy for the Treatment of Ventilator-Associated Pneumonia (VAP) Shows 100% Efficacy in an in vitro Study with MRSA and Human Lung Cells (Alveoli)

Affluent Medical Announces Promising Performance Results for its Artus Artificial Urinary Sphincter and Receives Approval to Initiate Pivotal Phase of its Clinical Trial

Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board

Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025